The molecular pathogenesis of osteosarcoma: A review

Sarcoma

Volumn 2011, Issue , 2011, Pages

  Choong, Peter F M ^a,c   Broadhead, Matthew L ^a   Clark, Jonathan C M ^a   Myers, Damian E ^a   Dass, Crispin R ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b VICTORIA UNIVERSITY   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; ANILINE; ANTINEOPLASTIC AGENT; ASBESTOS; BERYLLIUM; CHROMIUM DERIVATIVE; CISPLATIN; CONNECTIVE TISSUE GROWTH FACTOR; DOCETAXEL; MATRIX METALLOPROTEINASE; MESSENGER RNA; MYC PROTEIN; PROTEIN P53; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; RETINOBLASTOMA PROTEIN; SHORT HAIRPIN RNA; SILICATE; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; BONE GROWTH; CANCER GENE THERAPY; CANCER GROWTH; CANCER INVASION; CANCER RESISTANCE; CARCINOGENESIS; CELL ANCHORAGE; CELL MIGRATION; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CHEMOSENSITIVITY; CHEMOSENSITIZATION; CHROMOSOME ABERRATION; ENVIRONMENTAL FACTOR; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIMIAN VIRUS 40; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION; VIRAL GENE THERAPY; VIRUS CARCINOGENESIS;

EID: 79959228980     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2011/959248     Document Type: Review

References (136)

1. Bielack S. S., Kempf-Bielack B., Delling G., Exner G. U., Flege S., Helmke K., Kotz R., Salzer-Kuntschik M., Wemer M., Winkelmann W., Zoubek A., Jrgens H., Winkler K., Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols Journal of Clinical Oncology 2002 20 3 776 790 (Pubitemid 34111386)
2. Vigorita V. J., Orthopaedic Pathology 2008 Philadelphia, Pa, USA Lippincott, Williams Wilkins
3. Canale S. T., Beaty J. H., Campbell's Operative Orthopaedics 2008 Mosby Elsvier
4. Cotterill S. J., Wright C. M., Pearce M. S., Craft A. W., Stature of young people with malignant bone tumors Pediatric Blood and Cancer 2004 42 1 59 63 (Pubitemid 38173458)
5. Gelberg K. H., Fitzgerald E. F., Hwang S. A., Dubrow R., Growth and development and other risk factors for osteosarcoma in children and young adults International Journal of Epidemiology 1997 26 2 272 278 (Pubitemid 27190297)
6. Marina N., Gebhardt M., Teot L., Gorlick R., Biology and therapeutic advances for pediatric osteosarcoma Oncologist 2004 9 4 422 441 (Pubitemid 39014554)
7. Longhi A., Pasini A., Cicognani A., Baronio F., Pellacani A., Baldini N., Bacci G., Height as a risk factor for osteosarcoma Journal of Pediatric Hematology/Oncology 2005 27 6 314 318 (Pubitemid 40885161)
8. Polednak A. P., Bone cancer among female radium dial workers. Latency periods and incidence rates by time after exposure: brief communication Journal of the National Cancer Institute 1978 60 1 77 82 (Pubitemid 8287171)
9. Picci P., Osteosarcoma (osteogenic sarcoma) Orphanet Journal of Rare Diseases 2007 2 1, article 6
10. Longhi A., Barbieri E., Fabbri N., Macchiagodena M., Favale L., Lippo C., Salducca N., Bacci G., Radiation-induced osteosarcoma arising 20 years after the treatment of Ewing's sarcoma Tumori 2003 89 5 569 572 (Pubitemid 37541623)
11. Paulino A. C., Fowler B. Z., Secondary neoplasms after radiotherapy for a childhood solid tumor Pediatric Hematology and Oncology 2005 22 2 89 101 (Pubitemid 40315508)
12. Rani A. S., Kumar S., Transformation of non-tumorigenic osteoblast-like human osteosarcoma cells by hexavalent chromates: alteration of morphology, induction of anchorage-independence and proteolytic function Carcinogenesis 1992 13 11 2021 2027
13. Dutra F. R., Largent E. J., Osteosarcoma induced by beryllium oxide American Journal of Pathology 1950 26 2 197 209
14. Mazabraud A., Experimental production of bone sarcomas in the rabbit by a single local injection of beryllium Bulletin du Cancer 1975 62 1 49 58
15. Tan M. L., Choong P. F. M., Dass C. R., Osteosarcoma: conventional treatment vs. gene therapy Cancer Biology and Therapy 2009 8 2 106 117
16. Mendoza S. M., Konishi T., Miller C. W., Integration of SV40 in human osteosarcoma DNA Oncogene 1998 17 19 2457 2462 (Pubitemid 28544715)
17. Engels E. A., Cancer risk associated with receipt of vaccines contaminated with simian virus 40: epidemiologic research Expert Review of Vaccines 2005 4 2 197 206 (Pubitemid 40525061)
18. Lpez-Ros F., Illei P. B., Rusch V., Ladanyi M., Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids The Lancet 2004 364 9440 1157 1166 (Pubitemid 39296603)
19. Manfredi J. J., Dong J., Liu W. J., Resnick-Silverman L., Qiao R., Chahinian P., Saric M., Gibbs A. R., Phillips J. I., Murray J., Axten C. W., Nolan R. P., Aaronson S. A., Evidence against a role for SV40 in human mesothelioma Cancer Research 2005 65 7 2602 2609 (Pubitemid 40490058)
20. Greenspan A., Jundt G., Remagen W., Differential Diagnosis in Orthopaedic Oncology 2007 Philadelphia, Pa, USA Lippincott Williams Wilkins
21. German J., Crippa L. P., Bloom D., Bloom's syndrome. III. Analysis of the chromosome aberration characteristic of this disorder Chromosoma 1974 48 4 361 366
22. Fukuchi K., Martin G. M., Monnat R. J. Jr., Mutator phenotype of Werner syndrome is characterized by extensive deletions Proceedings of the National Academy of Sciences of the United States of America 1989 86 15 5893 5897 (Pubitemid 19217554)
23. Smida J., Baumhoer D., Rosemann M., Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma Clinical Cancer Research 2010 16 16 4256 4267
24. Ta H. T., Dass C. R., Choong P. F. M., Dunstan D. E., Osteosarcoma treatment: state of the art Cancer and Metastasis Reviews 2009 28 1-2 247 263
25. Alberts B., Johnson A., Lewis J., Molecular biology of the cell. Garland Science, 2008
26. Teodoro J. G., Evans S. K., Green M. R., Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome Journal of Molecular Medicine 2007 85 11 1175 1186 (Pubitemid 47622219)
27. Hauben E. I., Arends J., Vandenbroucke J. P., van Asperen C. J., van Marck E., Hogendoorn P. C. W., Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma European Journal of Human Genetics 2003 11 8 611 618 (Pubitemid 37038776)
28. McIntyre J. F., Smith-Sorensen B., Friend S. H., Kassell J., Borresen A. L., Yu Xin Yan., Russo C., Sato J., Barbier N., Miser J., Malkin D., Gebhardt M. C., Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma Journal of Clinical Oncology 1994 12 5 925 930 (Pubitemid 24145318)
29. Chandar N., Billig B., McMaster J., Novak J., Inactivation of p53 gene in human and murine osteosarcoma cells British Journal of Cancer 1992 65 2 208 214
30. Miller C. W., Aslo A., Won A., Tan M., Lampkin B., Koeffler H. P., Alterations of the p53, Rb and MDM2 genes in osteosarcoma Journal of Cancer Research and Clinical Oncology 1996 122 9 559 565 (Pubitemid 26284557)
31. Ganjavi H., Gee M., Narendran A., Parkinson N., Krishnamoorthy M., Freedman M. H., Malkin D., Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines: sensitization to cisplatin and doxorubicin Cancer Gene Therapy 2006 13 4 415 419
32. Hu X., Yu A. X., Qi B. W., The expression and significance of IDH1 and p53 in osteosarcom Journal of Experimental Clinical Cancer Research 2010 29 43
33. Park H. R., Won Jung W., Bertoni F., Bacchini P., Hoon Park J., Kim Y. W., Park Y. K., Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma Pathology Research and Practice 2004 200 6 439 445 (Pubitemid 38937183)
34. Lonardo F., Ueda T., Huvos A. G., Healey J., Ladanyi M., p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate Cancer 1997 79 8 1541 1547 (Pubitemid 27154785)
35. Park Y. B., Kim H. S., Oh J. H., Lee S. H., The co-expression of p53 protein and P-glycoprotein is correlated to a poor prognosis in osteosarcoma International Orthopaedics 2001 24 6 307 310 (Pubitemid 32176313)
36. Longhi A., Osteosarcoma in blood relatives Oncology Reports 2001 8 1 131 136 (Pubitemid 33758215)
37. Serena Benassi M., Molendini L., Gamberi G., Ragazzini P., Rosa Sollazzo M., Merli M., Asp J., Magagnoli G., Alteration of pRb/p16/cdk4 regulation in human osteosarcoma International Journal of Cancer 1999 84 5 489 493
38. Heinsohn S., Evermann U., Zur Stadt U., Bielack S., Kabisch H., Determination of the prognostic value of loss of heterozygosity at the retinoblastoma gene in osteosarcoma International Journal of Oncology 2007 30 5 1205 1214
39. Wadayama B. I., Toguchida J., Shimizu T., Ishizaki K., Sasaki M. S., Kotoura Y., Yamamuro T., Mutation spectrum of the retinoblastoma gene in osteosarcomas Cancer Research 1994 54 11 3042 3048 (Pubitemid 24187793)
40. Feugeas O., Guriec N., Babin-Boilletot A., Marcellin L., Simon P., Babin S., Thyss A., Hofman P., Terrier P., Kalifa C., Brunat-Mentigny M., Patricot L. M., Oberling F., Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma Journal of Clinical Oncology 1996 14 2 467 472 (Pubitemid 26051009)
41. Iida K., Nobori T., Matsumine A., Isaka A., Seto M., Shiraishi T., Uchida A., Effect of retinoblastoma tumor suppressor gene expression on chemosensitivity of human osteosarcoma cell lines Oncology Reports 2003 10 6 1961 1965
42. Wu J. X., Carpenter P. M., Gresens C., Keh R., Niman H., Morris J. W. S., Mercola D., The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomas Oncogene 1990 5 7 989 1000
43. Franchi A., Calzolari A., Zampi G., Immunohistochemical detection of c-fos and c-jun expression in osseous and cartilaginous tumours of the skeleton Virchows Archiv 1998 432 6 515 519 (Pubitemid 28297558)
44. Gamberi G., Benassi M. S., Bohling T., Ragazzini P., Molendini L., Sollazzo M. R., Pompetti F., Merli M., Magagnoli G., Balladelli A., Picci P., C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression Oncology 1998 55 6 556 563 (Pubitemid 28479115)
45. Wang Z. Q., Liang J., Schellander K., Wagner E. F., Grigoriadis A. E., c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos Cancer Research 1995 55 24 6244 6251
46. Leaner V. D., Chick J. F., Donninger H., Linniola I., Mendoza A., Khanna C., Birrer M. J., Inhibition of AP-1 transcriptional activity blocks the migration, invasion, and experimental metastasis of murine osteosarcoma American Journal of Pathology 2009 174 1 265 275
47. Tan M. L., Choong P. F. M., Dass C. R., Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours Cancer Cell International 2010 10, article 9
48. Shimizu T., Ishikawa T., Sugihara E., c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis Oncogene 2010 29 42 5687 5699
49. Hattinger C. M., Stoico G., Michelacci F., Pasello M., Scionti I., Remondini D., Castellani G. C., Fanelli M., Scotlandi K., Picci P., Serra M., Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines Genes Chromosomes and Cancer 2009 48 4 289 309
50. Scionti I., Michelacci F., Pasello M., Hattinger C. M., Alberghini M., Manara M. C., Bacci G., Ferrari S., Scotlandi K., Picci P., Serra M., Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma Annals of Oncology 2008 19 8 1500 1508
51. Xie X. K., Yang D. S., Ye Z. M., Tao H. M., Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines Chemotherapy 2009 55 6 433 440
52. Arvanitis C., Bendapudi P. K., Tseng J. R., Gambhir S. S., Felsher D. W., 18 F and 18 FDG PET imaging of osteosarcoma to non-invasively monitor in situ changes in cellular proliferation and bone differentiation upon MYC inactivation Cancer Biology and Therapy 2008 7 12 1947 1951
53. Franchi A., Arganini L., Baroni G., Calzolari A., Capanna R., Campanacci D., Caldora P., Masi L., Brandi M. L., Zampi G., Expression of transforming growth factor isoforms in osteosarcoma variants: association of TGF 1 with high-grade osteosarcomas Journal of Pathology 1998 185 3 284 289 (Pubitemid 28320050)
54. Navid F., Letterio J. J., Yeung C. L., Pegtel M., Helman L. J., Autocrine transforming growth factor- growth pathway in murine osteosarcoma cell lines associated with inability to affect phosphorylation of retinoblastoma protein Sarcoma 2000 4 3 93 102
55. Hu Y. S., Pan Y., Li W. H., Zhang Y., Li J., Ma B. A., Int7G24A variant of transforming growth factor-beta receptor 1 is associated with osteosarcoma susceptibility in a Chinese population. Medical Oncology. In Press
56. Hu Y. S., Pan Y., Li W. H., Zhang Y., Li J., Ma B. A., Association between TGFBR16A and osteosarcoma: a Chinese case-control study BMC Cancer 2010 10, article 169
57. Rikhof B., De Jong S., Suurmeijer A. J. H., Meijer C., van der Graaf W. T. A., The insulin-like growth factor system and sarcomas Journal of Pathology 2009 217 4 469 482
58. Wang Y. H., Xiong J., Wang S. F., Yu Y., Wang B., Chen Y. X., Shi H. F., Qiu Y., Lentivirus-mediated shRNA targeting insulin-like growth factor-1 receptor (IGF-1R) enhances chemosensitivity of osteosarcoma cells in vitro and in vivo Molecular and Cellular Biochemistry 2010 341 1-2 225 233
59. Dong J., Demarest S. J., Sereno A., Combination of two insulin-like growth factor-I receptor inhibitory antibodies targeting distinct epitopes leads to an enhanced antitumor response Molecular Cancer Therapeutics 2010 9 9 2593 2604
60. Kolb E. A., Kamara D., Zhang W., Lin J., Hingorani P., Baker L., Houghton P., Gorlick R., R1507, a fully human monoclonal antibody targeting IGF-1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts Pediatric Blood and Cancer 2010 55 1 67 75
61. Lau L. F., Lam S. C. T., The CCN family of angiogenic regulators: the integrin connection Experimental Cell Research 1999 248 1 44 57 (Pubitemid 29393928)
62. Nishida T., Nakanishi T., Asano M., Shimo T., Takigawa M., Effects of CTGF/Hcs 24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro Journal of Cellular Physiology 2000 184 2 197 206 (Pubitemid 30432311)
63. Perbal B., Zuntini M., Zambelli D., Serra M., Sciandra M., Cantiani L., Lucarelli E., Picci P., Scotlandi K., Prognostic value of CCN3 in osteosarcoma Clinical Cancer Research 2008 14 3 701 709 (Pubitemid 351231150)
64. Rodda C. P., Kubota M., Heath J. A., Ebeling P. R., Moseley J. M., Care A. D., Caple I. W., Martin T. J., Evidence for a novel parathyroid hormone-related protein in fetal lamb parathyroid glands and sheep placenta: comparisons with a similar protein implicated in humoral hypercalcaemia of malignancy Journal of Endocrinology 1988 117 2 261 271
65. Yang R., Hoang B. H., Kubo T., Kawano H., Chou A., Sowers R., Huvos A. G., Meyers P. A., Healey J. H., Gorlick R., Over-expression of parathyroid hormone type 1 receptor confers an aggressive phenotype in osteosarcoma International Journal of Cancer 2007 121 5 943 954 (Pubitemid 47101629)
66. Gagiannis S., Mller M., Uhlemann S., Koch A., Melino G., Krammer P. H., Nawroth P. P., Brune M., Schilling T., Parathyroid hormone-related protein confers chemoresistance by blocking apoptosis signaling via death receptors and mitochondria International Journal of Cancer 2009 125 7 1551 1557
67. Berdiaki A., Datsis G. A., Nikitovic D., Tsatsakis A., Katonis P., Karamanos N. K., Tzanakakis G. N., Parathyroid hormone (PTH) peptides through the regulation of hyaluronan metabolism affect osteosarcoma cell migration IUBMB Life 2010 62 5 377 386
68. Pasquini G. M. F., Davey R. A. M., Ho P. W. M., Michelangeli V. P., Grill V., Kaczmarczyk S. J., Zajac J. D., Local secretion of parathyroid hormone-related protein by an osteoblastic osteosarcoma (UMR 106-01) cell line results in growth inhibition Bone 2002 31 5 598 605 (Pubitemid 35449702)
69. Broadhead M. L., Dass C. R., Choong P. F. M., Cancer cell apoptotic pathways mediated by PEDF: prospects for therapy Trends in Molecular Medicine 2009 15 10 461 467
70. Jan Y., Matter M., Pai J. T., Chen Y. L., Pilch J., Komatsu M., Ong E., Fukuda M., Ruoslahti E., A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors Cell 2004 116 5 751 762 (Pubitemid 38326732)
71. Janes S. M., Watt F. M., Switch from v 5 to v 6 integrin expression protects squamous cell carcinomas from anoikis Journal of Cell Biology 2004 166 3 419 431 (Pubitemid 39031244)
72. Nicholson K. M., Anderson N. G., The protein kinase B/Akt signalling pathway in human malignancy Cellular Signalling 2002 14 5 381 395 (Pubitemid 34214843)
73. Coniglio S. J., Jou T. S., Symons M., Rac1 protects epithelial cells against anoikis Journal of Biological Chemistry 2001 276 30 28113 28120
74. Ley R., Ewings K. E., Hadfield K., Howes E., Balmanno K., Cook S. J., Extracellular signal-regulated kinases 1/2 are serum-stimulated Bim kinases that bind to the BH3-only protein bim causing its phosphorylation and turnover Journal of Biological Chemistry 2004 279 10 8837 8847 (Pubitemid 38295942)
75. Hicklin D. J., Ellis L. M., Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis Journal of Clinical Oncology 2005 23 5 1011 1027 (Pubitemid 46202320)
76. Dvorak H. F., Angiogenesis: update 2005 Journal of Thrombosis and Haemostasis 2005 3 8 1835 1842 (Pubitemid 41716570)
77. Shibuya M., Claesson-Welsh L., Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis Experimental Cell Research 2006 312 5 549 560 (Pubitemid 43290332)
78. Nagy J. A., Dvorak A. M., Dvorak H. F., VEGF-A and the induction of pathological angiogenesis Annual Review of Pathology 2007 2 251 275 (Pubitemid 46448066)
79. Matsumoto T., Mugishima H., Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis Journal of Atherosclerosis and Thrombosis 2006 13 3 130 135
80. Liao D., Johnson R. S., Hypoxia: a key regulator of angiogenesis in cancer Cancer and Metastasis Reviews 2007 26 2 281 290 (Pubitemid 47101669)
81. Carmeliet P., VEGF as a key mediator of angiogenesis in cancer Oncology 2005 69 3 4 10 (Pubitemid 41680947)
82. Tran J., Rak J., Sheehan C., Saibil S. D., Lacasse E., Korneluk R. G., Kerbel R. S., Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells Biochemical and Biophysical Research Communications 1999 264 3 781 788
83. Yancopoulos G. D., Davis S., Gale N. W., Rudge J. S., Wiegand S. J., Holash J., Vascular-specific growth factors and blood vessel formation Nature 2000 407 6801 242 248
84. Lobov I. B., Renard R. A., Papadopoulos N., Gale N. W., Thurston G., Yancopoulos G. D., Wiegand S. J., Delta-like ligand 4 (DII4) is induced by VEGF as a negative regulator of angiogenic sprouting Proceedings of the National Academy of Sciences of the United States of America 2007 104 9 3219 3224 (Pubitemid 46364140)
85. Kaya M., Wada T., Akatsuka T., Kawaguchi S., Nagoya S., Shindoh M., Higashino F., Mezawa F., Okada F., Ishii S., Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis Clinical Cancer Research 2000 6 2 572 577 (Pubitemid 30111481)
86. Hara H., Akisue T., Fujimoto T., Imabori M., Kawamoto T., Kuroda R., Fujioka H., Yamamoto T., Doita M., Kurosaka M., Expression of VEGF and its receptors and angiogenesis in bone and soft tissue tumors Anticancer Research 2006 26 6B 4307 4311 (Pubitemid 46039585)
87. Mantadakis E., Kim G., Reisch J., McHard K., Maale G., Leavey P. J., Timmons C., Lack of prognostic significance of intratumoral angiogenesis in nonmetastatic osteosarcoma Journal of Pediatric Hematology/Oncology 2001 23 5 286 289 (Pubitemid 32662036)
88. Kreuter M., Bieker R., Bielaek S. S., Auras T., Buerger H., Gosheger G., Jurgens H., Berdel W. E., Mesters R. M., Prognostic relevance of increased angiogenesis in osteosarcoma Clinical Cancer Research 2004 10 24 8531 8537 (Pubitemid 40053420)
89. Ren B., Yee K. O., Lawler J., Khosravi-Far R., Regulation of tumor angiogenesis by thrombospondin-1 Biochimica et Biophysica Acta 2006 1765 2 178 188
90. Cai J., Parr C., Watkins G., Jiang W. G., Boulton M., Decreased pigment epithelium-derived factor expression in human breast cancer progression Clinical Cancer Research 2006 12 11, part 1 3510 3517
91. Clark J. C. M., Thomas D. M., Choong P. F. M., Dass C. R., RECKa newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer Cancer and Metastasis Reviews 2007 26 3-4 675 683 (Pubitemid 350115122)
92. Quan G. M. Y., Ojaimi J., Li Y., Kartsogiannis V., Zhou H., Choong P. F. M., Localization of pigment epithelium-derived factor in growing mouse bone Calcified Tissue International 2005 76 2 146 153 (Pubitemid 40684962)
93. Moses M. A., Wiederschain D., Wu I., Fernandez C. A., Ghazizadeh V., Lane W. S., Flynn E., Sytkowski A., Tao T., Langer R., Troponin I is present in human cartilage and inhibits angiogenesis Proceedings of the National Academy of Sciences of the United States of America 1999 96 6 2645 2650 (Pubitemid 29148771)
94. Ek E. T. H., Dass C. R., Contreras K. G., Choong P. F. M., Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis Cancer Gene Therapy 2007 14 7 616 626 (Pubitemid 46912035)
95. Ek E. T. H., Dass C. R., Contreras K. G., Choong P. F. M., Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor Clinical and Experimental Metastasis 2007 24 2 93 106 (Pubitemid 46669247)
96. Luo B. H., Carman C. V., Springer T. A., Structural basis of integrin regulation and signaling Annual Review of Immunology 2007 25 619 647 (Pubitemid 46697919)
97. Berrier A. L., Yamada K. M., Cell-matrix adhesion Journal of Cellular Physiology 2007 213 3 565 573 (Pubitemid 350058247)
98. Nimnual A. S., Taylor L. J., Bar-Sagi D., Redox-dependent downregulation of Rho by Rac Nature Cell Biology 2003 5 3 236 241 (Pubitemid 36322251)
99. Fromigu O., Hamidouche Z., Marie P. J., Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion Journal of Biological Chemistry 2008 283 45 30549 30556
100. Lo C. M., Wang H. B., Dembo M., Wang Y. L., Cell movement is guided by the rigidity of the substrate Biophysical Journal 2000 79 1 144 152 (Pubitemid 30436733)
101. Paszek M. J., Zahir N., Johnson K. R., Lakins J. N., Rozenberg G. I., Gefen A., Reinhart-King C. A., Margulies S. S., Dembo M., Boettiger D., Hammer D. A., Weaver V. M., Tensional homeostasis and the malignant phenotype Cancer Cell 2005 8 3 241 254 (Pubitemid 41317594)
102. Hunter K. W., Ezrin, a key component in tumor metastasis Trends in Molecular Medicine 2004 10 5 201 204 (Pubitemid 38581790)
103. Khanna C., Wan X., Bose S., Cassaday R., Olomu O., Mendoza A., Yeung C., Gorlick R., Hewitt S. M., Helman L. J., The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis Nature Medicine 2004 10 2 182 186 (Pubitemid 38524889)
104. Birkedal-Hansen H., Moore W. G. I., Bodden M. K., Windsor L. J., Birkedal-Hansen B., DeCarlo A., Engler J. A., Matrix metalloproteinases: a review Critical Reviews in Oral Biology and Medicine 1993 4 2 197 250 (Pubitemid 23103292)
105. Chakraborti S., Mandal M., Das S., Mandal A., Chakraborti T., Regulation of matrix metalloproteinases. An overview Molecular and Cellular Biochemistry 2003 253 1-2 269 285 (Pubitemid 37321735)
106. Oh J., Takahashi R., Kondo S., Mizoguchi A., Adachi E., Sasahara R. M., Nishimura S., Imamura Y., Kitayama H., Alexander D. B., Ide C., Horan T. P., Arakawa T., Yoshida H., Nishikawa S. I., Itoh Y., Seiki M., Itohara S., Takahashi C., Noda M. M., The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis Cell 2001 107 6 789 800 (Pubitemid 34033671)
107. Bergers G., Brekken R., McMahon G., Vu T. H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., Hanahan D., Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nature Cell Biology 2000 2 10 737 744
108. Burbridge M. F., Cog F., Galizzi J. P., Boutin J. A., West D. C., Tucker G. C., The role of the matrix metalloproteinases during in vitro vessel formation Angiogenesis 2002 5 3 215 226 (Pubitemid 36687524)
109. Masson V., Rodriguez de la Ballina L., Munaut C., Wielockx B., Jost M., Maillard C., Blacher S., Bajou K., Itoh T., Itohara S., Werb Z., Libert C., Foidart J. M., Nol A., Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes FASEB Journal 2005 19 2 234 236 (Pubitemid 40189266)
110. Choong P. F., Nadesapillai A. P., Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis Clinical Orthopaedics and Related Research 2003 415 supplement S46 S58
111. Pillay V., Dass C. R., Choong P. F. M., The urokinase plasminogen activator receptor as a gene therapy target for cancer Trends in Biotechnology 2007 25 1 33 39 (Pubitemid 46001467)
112. Choong P. F. M., Fern M., kermans M., Willm H., Lnostrm E., Gustafson P., Alvegrd T., Rydholm A., Urokinase-plasminogen-activator levels and prognosis in 69 soft-tissue sarcomas International Journal of Cancer 1996 69 4 268 272 (Pubitemid 26298289)
113. Dass C. R., Nadesapillai A. P. W., Robin D., Howard M. L., Fisher J. L., Zhou H., Choong P. F. M., Downregulation of uPAR confirms link in growth and metastasis of osteosarcoma Clinical and Experimental Metastasis 2005 22 8 643 652 (Pubitemid 44259525)
114. Guise T. A., Chirgwin J. M., Transforming growth factor-beta in osteolytic breast cancer bone metastases Clinical Orthopaedics and Related Research 2003 415 supplement S32 S38
115. Quinn J. M. W., Itoh K., Udagawa N., Husler K., Yasuda H., Shima N., Mizuno A., Higashio K., Takahashi N., Suda T., Martin T. J., Gillespie M. T., Transforming growth factor affects osteoclast differentiation via direct and indirect actions Journal of Bone and Mineral Research 2001 16 10 1787 1794 (Pubitemid 32911484)
116. Kingsley L. A., Fournier P. G. J., Chirgwin J. M., Guise T. A., Molecular biology of bone metastasis Molecular Cancer Therapeutics 2007 6 10 2609 2617 (Pubitemid 350058141)
117. Chirgwin J. M., Guise T. A., Skeletal metastases: decreasing tumor burden by targeting the bone microenvironment Journal of Cellular Biochemistry 2007 102 6 1333 1342 (Pubitemid 350223937)
118. Kinpara K., Osteoclast differentiation factor in human osteosarcoma cell line Journal of Immunoassay 2000 21 4 327 340
119. Hofbauer L. C., Heufelder A. E., Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis European Journal of Endocrinology 1998 139 2 152 154 (Pubitemid 28389671)
120. Takayanagi H., The role of NFAT in osteoclast formation Annals of the New York Academy of Sciences 2007 1116 227 237 (Pubitemid 350274348)
121. Stoch S. A., Wagner J. A., Cathepsin K inhibitors: a novel target for osteoporosis therapy Clinical Pharmacology and Therapeutics 2008 83 1 172 176
122. Le Gall C., Bellahcne A., Bonnelye E., Gasser J. A., Castronovo V., Green J., Zimmermann J., Clzardin P., A cathepsin K inhibitor reduces breast cancer-induced osteolysis and skeletal tumor burden Cancer Research 2007 67 20 9894 9902 (Pubitemid 47621238)
123. Husmann K., Muff R., Bolander M. E., Sarkar G., Born W., Fuchs B., Cathepsins and osteosarcoma: expression analysis identifies cathepsin K as an indicator of metastasis Molecular Carcinogenesis 2008 47 1 66 73
124. Tanaka S., Amling M., Neff L., Peyman A., Uhlmann E., Levy J. B., Baron R., c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption Nature 1996 383 6600 528 531 (Pubitemid 26346179)
125. Schlessinger J., New roles for Src kinases in control of cell survival and angiogenesis Cell 2000 100 3 293 296 (Pubitemid 30353084)
126. Glantschnig H., Fisher J. E., Wesolowski G., M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase Cell Death Differ 2003 10 10 1165 1177 (Pubitemid 37258582)
127. Rucci N., ua M., Teti A., Inhibition of protein kinase c-Src as a therapeutic approach for cancer and bone metastases Anti-Cancer Agents in Medicinal Chemistry 2008 8 3 342 349 (Pubitemid 351761438)
128. Akiyama T., Dass C. R., Choong P. F. M., Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway Molecular Cancer Therapeutics 2008 7 11 3461 3469
129. Tanaka S., Nakamura K., Takahasi N., Suda T., Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system Immunological Reviews 2005 208 30 49 (Pubitemid 41746383)
130. Lamoureux F., Richard P., Wittrant Y., Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption Cancer Research 2007 67 15 7308 7318 (Pubitemid 47206560)
131. Ottaviani G., Jaffe N., The epidemiology of osteosarcoma Cancer Treatment and Research 2009 152 3 13
132. Guise T. A., O'Keefe R., Randall R. L., Terek R. M., Molecular biology and therapeutics in musculoskeletal oncology Journal of Bone and Joint Surgery. American 2009 91 3 724 732
133. Broadhead M. L., Akiyama T., Choong P. F. M., Dass C. R., The pathophysiological role of PEDF in bone diseases Current Molecular Medicine 2010 10 3 296 301
134. Ek E. T. H., Dass C. R., Contreras K. G., Choong P. F. M., Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor Clinical and Experimental Metastasis 2007 24 2 93 106 (Pubitemid 46669247)
135. Ek E. T. H., Dass C. R., Contreras K. G., Choong P. F. M., PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma Journal of Orthopaedic Research 2007 25 12 1671 1680 (Pubitemid 350293816)
136. Kang H. G., Kim H. S., Kim K. J., Oh J. H., Lee M. R., Seol S. M., Han I., RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness Journal of Orthopaedic Research 2007 25 5 696 702 (Pubitemid 46730522)